Startup Atlas · Pharmaceuticals
Anupam Rasayan India
Listed Surat custom-synthesis and specialty-chemicals maker; completed a Rs1,750 Cr controlling-stake buy of Bliss GVS Pharma in Sep 2026, its third acquisition.
UndisclosedTotal funding (tracked)
0Funding rounds
—Last round
Publicly listed · NSE:ANURAS
NSE:ANURAS View Anupam Rasayan India's live share price on Google Finance ↗
Anupam Rasayan India: Funding Rounds
No funding rounds tracked for Anupam Rasayan India yet.
Acquisitions
| Date | Acquirer | Acquired | Amount | Source |
|---|---|---|---|---|
| 29 Sep 2026 | Anupam Rasayan India | Bliss GVS Pharma | $182.23 Mn | source |
News on Anupam Rasayan India
No coverage of Anupam Rasayan India linked yet.
L Litmus · by Lapaas
Got an idea like this one? Validate it with the same 9-block framework, free.
Start Free ValidationFAQs on Anupam Rasayan India
What does Anupam Rasayan India do?
Listed Surat custom-synthesis and specialty-chemicals maker; completed a Rs1,750 Cr controlling-stake buy of Bliss GVS Pharma in Sep 2026, its third acquisition.
Where is Anupam Rasayan India headquartered?
Anupam Rasayan India is headquartered in Surat, Gujarat, India.
Sources & corrections.
Every fact on this page is compiled from cited public sources — follow the "source" links beside each entry. Profile sources: www.tofler.in economictimes.indiatimes.com · Last verified 5 Oct 2026. · Report a correction